Dear All RAPS Associates,
With the BREXIT implementation around the corner it may be seen that Reference Medicinal Product will also get discontinued from EU market which are being from UK Origin.
Do we get any information for such discontinued products, also those products which are under pipeline of development/registration with UK Reference Medicinal Product, will severely be affected.
Please guide what shall be the development/registration strategy in such light of BREXIT.
Thanks in Advance.
------------------------------
Tushar Premchandani PHD
Assistant Manager RA
Olive Healthcare
Daman
India
------------------------------